14 Vaccine Development Companies From Around The World

Defence Therapeutics

Service, Biotechnology, Vancouver, Canada

Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in ...

PRiME Vector Technologies GmbH

Manufacturer, Biotechnology, Tübingen, Germany

The Challenge: Companies in the vaccine industry are facing the challenge of producing highly effective customized vaccines in a quick and cost-effective way, both, in the fields of oncology and infectious diseases. Currently, neither is possible with the common platforms due to excessive ...

AstriVax NV

Service, Pharma, Heverlee, Belgium

AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax has secured a seed round of € 30 million with a strong investor syndicate to continue building the vaccine technology platform and bring the first ...

Frame Cancer Therapeutics

Service, Biotechnology, Amsterdam, Netherlands

Frame Cancer Therapeutics is a privately funded startup company in the Amsterdam Science Park founded in December 2018. Frame Therapeutics’ goal is to develop its proprietary approach for immunotherapy against cancer, which is based on precise analysis of the DNA and RNA of the tumor of a patient ...

CimCure

Service, Biotechnology, Amsterdam, Netherlands

CimCure is a 2016 spin-off from Amsterdam UMC. CimCure focuses on the design and development of a novel class of active cancer immunotherapies. The company develops cancer vaccines through its proprietary Immune-Boost (iBoost) technology of targeted conjugate vaccines. They have identified ...

Nouscom AG

Manufacturer, Biotechnology, Basel, Switzerland

Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an ...

Themis Bioscience GmbH

Service, Biotechnology, Wien, Austria

Themis Bioscience is an international biotech company that successfully develops vaccines against emerging and specialist indications. Exploiting the full potential of our proprietary Themaxyn® platform we are able to identify and rapidly advance vaccine candidates at various stages of ...

Imophoron Ltd

Manufacturer, Biotechnology, Bristol, United Kingdom

Imophoron was founded in 2017 and is based at Science Creates in Bristol, UK. Imophoron has developed a novel next-generation nanoparticle platform, ADDomer™, initially focused on the development of vaccines to combat present and future infectious diseases, including ‘Disease X’ outbreaks. ...

RocketVax AG

Manufacturer, Biotechnology, Basel, Switzerland

The company brings together both scientific and operational expertise from various institutions in Switzerland and Germany and aims to become a world leading centre of excellence for novel vaccine development. RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator ...

Virometix AG

Manufacturer, Pharma, Schlieren, Switzerland